Financial Gravity Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-72
| Closed | -$3.12K | – | 1904 |
|
2024
Q1 | $3.12K | Sell |
72
-363
| -83% | -$15.7K | ﹤0.01% | 977 |
|
2023
Q4 | $15.5K | Buy |
435
+22
| +5% | +$783 | ﹤0.01% | 719 |
|
2023
Q3 | $14.6K | Buy |
413
+377
| +1,047% | +$13.4K | ﹤0.01% | 568 |
|
2023
Q2 | $8.93K | Hold |
36
| – | – | 0.02% | 370 |
|
2023
Q1 | $4.9K | Buy |
36
+1
| +3% | +$136 | 0.15% | 154 |
|
2022
Q4 | $9.55K | Sell |
35
-603
| -95% | -$164K | 0.05% | 264 |
|
2022
Q3 | $4.61K | Sell |
638
-946
| -60% | -$6.83K | 0.16% | 130 |
|
2022
Q2 | $11.5K | Buy |
1,584
+704
| +80% | +$5.09K | 0.36% | 55 |
|
2022
Q1 | $6.22K | Buy |
880
+669
| +317% | +$4.73K | 0.17% | 125 |
|
2021
Q4 | $3 | Buy |
+211
| New | +$3 | ﹤0.01% | 918 |
|
2021
Q3 | – | Hold |
0
| – | -$40K | – | 652 |
|
2021
Q2 | – | Hold |
0
| – | -$13 | – | 636 |
|
2021
Q1 | – | Sell |
-45
| Closed | -$2K | – | 704 |
|
2020
Q4 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 319 |
|
2020
Q2 | – | Sell |
-126
| Closed | -$5.95K | – | 377 |
|
2020
Q1 | $5.95K | Sell |
126
-524
| -81% | -$24.7K | 0.02% | 315 |
|
2019
Q4 | $72K | Sell |
650
-8
| -1% | -$886 | 0.05% | 462 |
|
2019
Q3 | $35K | Buy |
658
+19
| +3% | +$1.01K | 0.03% | 349 |
|
2019
Q2 | $32K | Buy |
639
+246
| +63% | +$12.3K | 0.03% | 401 |
|
2019
Q1 | $21K | Buy |
+393
| New | +$21K | 0.02% | 432 |
|
2018
Q3 | $23K | Buy |
476
+206
| +76% | +$9.95K | 0.02% | 454 |
|
2018
Q2 | $14K | Buy |
270
+7
| +3% | +$363 | 0.01% | 519 |
|
2018
Q1 | $13K | Buy |
+263
| New | +$13K | 0.01% | 550 |
|